DEL LABORATORIES CHANGES NAME OF SUBSIDIARY
DEL LABORATORIES CHANGES NAME OF SUBSIDIARY FARMINGDALE, N.Y., Dec. 3 /PRNewswire/ -- Dan K. Wassong, chief
executive officer of Del Laboratories, Inc. (AMEX: DLI) of Farmingdale, N.Y. has announced that effective Dec. 1, 1991, it is changing the name of its pharmaceutical subsidiary, Commerce Drug Company, Inc., to Del Pharmaceuticals, Inc.
"The change is being made in order to maximize the impact of the Del corporate name to the retail and wholesale trade, as well as the medical profession," said Charles J. Hinkaty, president of Del Pharmaceuticals, Inc. Commerce Drug Company, Inc., has been manufacturing and marketing over-the-counter drug products for over 50 years. It is best known for its Orajel and Propa pH product lines. The company was acquired by Del Laboratories, Inc. in 1963. For many years, Commerce Drug Company sales have consistently been growing at double digit rates. This growth can be attributed to several factors, including expanding the Orajel line with new formulations, increased advertising and promotion support, capitalizing on the potential of OTC pharmaceutical specialty brands like Stye and Boil Ease, and an aggressive new products program which generated Pronto Lice Control Treatment, Dermarest Anti-Itch Medication, Diaper Guard Diaper Rash Ointment, and Arthricare Topical Arthritis Pain Remedies. The executives who have guided the company's growth so successfully will continue in their posts. Del's management remains optimistic regarding the long-term growth potential of the rechristened subsidiary. -0- 12/3/91 /CONTACT: Charles J. Hinkaty, president of Del Pharmaceuticals and Del International, 516-752-2056/ (DLI) CO: Del Laboratories Inc.; Commerce Drug Company Inc. ST: New York IN: MTC SU: FC-OS -- NY037 -- 8734 12/03/91 11:53 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 3, 1991|
|Previous Article:||JACLYN DECLARES CASH DIVIDEND|
|Next Article:||/C O R R E C T I O N -- SIERRA ON-LINE/|